Literature DB >> 20401826

[The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients].

Kerstin Kühl1, Carina Kuhn, Klaus Kenn, Winfried Rief.   

Abstract

The study aimed to construct a questionnaire for COPD specific anxiety. Anxiety is a prevalent comorbid complication in COPD; however, assessment has focused on anxiety questionnaires in general and not on COPD related fears. Ninety-six patients with COPD (GOLD III/IV) participated in the study. Results of a principal component analysis with Varimax-rotation suggested 5 factors, jointly explaining 64.7% of variance. These factors depict: fear of social isolation, dyspnea related fear, fear of movement, fear of progression of disease, anxiety in relationships, and fear of LTOT. Satisfying internal consistencies (a=0.77-0.89) resulted for all factors. Validity analyses confirmed discriminant and convergent associations, as well as correlations with functional tests. Overall, the COPD-Anxiety-Questionnaire constitutes a reliable and valid measure to assess COPD-related fears. Moreover, it enables the early identification of COPD patients suffering from disease related anxiety. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 20401826     DOI: 10.1055/s-0030-1248281

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  8 in total

1.  Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.

Authors:  Tina Phan; Owen Carter; Claire Adams; Grant Waterer; Li Ping Chung; Maxine Hawkins; Cobie Rudd; Mel Ziman; Natalie Strobel
Journal:  Chron Respir Dis       Date:  2016-03-03       Impact factor: 2.444

Review 2.  Assessment of patient-reported symptoms of anxiety.

Authors:  Matthias Rose; Janine Devine
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

3.  Health anxiety and illness-related fears across diverse chronic illnesses: A systematic review on conceptualization, measurement, prevalence, course, and correlates.

Authors:  Sophie Lebel; Brittany Mutsaers; Christina Tomei; Caroline Séguin Leclair; Georden Jones; Danielle Petricone-Westwood; Nicole Rutkowski; Viviane Ta; Geneviève Trudel; Simone Zofia Laflamme; Andrée-Anne Lavigne; Andreas Dinkel
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

4.  The "can do, do do" concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms.

Authors:  J Carl; K Schultz; T Janssens; A von Leupoldt; K Pfeifer; W Geidl
Journal:  Respir Res       Date:  2021-10-06

5.  Disease-Specific Anxiety in Chronic Obstructive Pulmonary Disease: Translation and Initial Validation of a Questionnaire.

Authors:  Ingeborg Farver-Vestergaard; Sandra Rubio-Rask; Signe Timm; Camilla Fischer Christiansen; Ole Hilberg; Anders Løkke
Journal:  Front Psychol       Date:  2022-07-05

6.  Forecasting COPD hospitalization in the clinic: optimizing the chronic respiratory questionnaire.

Authors:  Beatriz Abascal-Bolado; Paul J Novotny; Jeff A Sloan; Craig Karpman; Megan M Dulohery; Roberto P Benzo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-22

7.  Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial.

Authors:  Wolfgang Geidl; Jana Semrau; René Streber; Nicola Lehbert; Silke Wingart; Alexander Tallner; Michael Wittmann; Rupert Wagner; Konrad Schultz; Klaus Pfeifer
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279

8.  Impact of Disease-Specific Fears on Pulmonary Rehabilitation Trajectories in Patients with COPD.

Authors:  Thomas Janssens; Zora Van de Moortel; Wolfgang Geidl; Johannes Carl; Klaus Pfeifer; Nicola Lehbert; Michael Wittmann; Konrad Schultz; Andreas von Leupoldt
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.